According to a recent research report titled “U.S. Precision Medicine Market (By Technology: Bioinformatics, Big Data Analytics, Drug Discovery, Gene Sequencing, Companion Diagnostics, Others; By Application: CNS, Immunology, Oncology, Respiratory, Others; By End-Use: Diagnostic Companies, Pharmaceutical Companies, Healthcare IT companies, Others; By Sequencing Technology; By Product; By Route of Administration) – Industry Analysis, Size, Share, Growth, Trends, and Forecast 2024-2033″ published by Precedence Research, the global U.S. precision medicine market size is projected to touch around USD 75.44 billion by 2033 and growing at a CAGR of 11.80% over the forecast period 2024 to 2033. This comprehensive study examines various factors and their impact on the growth of the U.S. precision medicine market.
Key Takeaways
- By technology, the drug discovery segment held the dominating share of the market in 2023.
- By application, the oncology segment dominated the U.S. precision medicine market in 2023.
- By end-use, the pharmaceutical company segment held the largest share of the market in 2023.
- By sequencing technology, the single molecule real-time sequencing segment is expected to dominate the market over the forecast period.
- By product, the consumables segment held the largest share of the market in 2023.
- By route of administration, the oral segment held the largest share of the market in 2023.
- By drugs, the Mepolizumab segment is observed to witness significant growth during the forecast period.
The report primarily focuses on the volume and value of the U.S. precision medicine market at the global, regional, and company levels. At the global level, the report analyzes historical data and prospects to present an overview of the overall market size. Regionally, the study emphasizes key regions such as North America, Europe, the Middle East & Africa, Latin America, and others.
Furthermore, the research report provides specific segmentations based on regions (countries), companies, and all market segments. This analysis offers insights into the growth and revenue trends during the historical period of 2017 to 2032, as well as the projected period. By understanding these segments, it becomes possible to identify the significance of different factors that contribute to market growth.
Download a Free Copy of Our Latest Sample Report@ https://www.precedenceresearch.com/sample/3722
The research also highlights significant progressions in both organic and inorganic growth strategies within the global U.S. precision medicine market. Numerous companies are placing emphasis on new product launches, gaining product approvals, and implementing various business expansion tactics. Moreover, the report presents detailed profiles of firms operating in the U.S. precision medicine market, along with their respective market strategies. Additionally, the study concentrates on prominent industry participants, furnishing details such as company profiles, product offerings, financial updates, and noteworthy advancements.
U.S. Precision Medicine Market Scope
| Report Coverage | Details |
| Growth Rate from 2024 to 2033 | CAGR of 11.80% |
| U.S. Market Size in 2023 | USD 24.84 Billion |
| U.S. Market Size by 2033 | USD 75.44 Billion |
| Base Year | 2024 |
| Forecast Period | 2024 to 2033 |
| Segments Covered | By Technology, By Application, By End-Use, By Sequencing Technology, By Product, By Route of Administration, and By Drugs |
Also read: Solar Carport Market Size to Attain USD 1,173.6 Million by 2033
Major Key Points Covered in Report:
Executive Summary: It includes key trends of the electric vehicle fuel cell market related to products, applications, and other crucial factors. It also provides analysis of the competitive landscape and CAGR and market size of the electric vehicle fuel cell market based on production and revenue.
Production and Consumption by Region: It covers all regional markets to which the research study relates. Prices and key players in addition to production and consumption in each regional market are discussed.
Key Players: Here, the report throws light on financial ratios, pricing structure, production cost, gross profit, sales volume, revenue, and gross margin of leading and prominent companies competing in the Electric vehicle fuel cell market.
Market Segments: This part of the report discusses product, application and other segments of the electric vehicle fuel cell market based on market share, CAGR, market size, and various other factors.
Research Methodology: This section discusses the research methodology and approach used to prepare the report. It covers data triangulation, market breakdown, market size estimation, and research design and/or programs.
Market Key Players
The report incorporates company profiles of key players in the market. These profiles encompass vital information such as product portfolio, key strategies, and a comprehensive SWOT analysis for each player. Additionally, the report presents a matrix illustrating the presence of each prominent player, enabling readers to gain actionable insights. This facilitates a thoughtful assessment of the market status and aids in predicting the level of competition in the U.S. precision medicine market.
U.S. Precision Medicine Market Players
- Biocrates Life Sciences
- Quest Diagnostics
- NanoString Technologies
- Pfizer
- AbbVie Inc.
- AstraZeneca
- Johnson & Johnson Services, Inc
- Thermo Fisher Scientific, Inc.
- Illumina, Inc.
- ARIEL Precision Medicine, Inc.
Segments Covered in the Report
By Technology
- Bioinformatics
- Big Data Analytics
- Drug Discovery
- Gene Sequencing
- Companion Diagnostics
- Others
By Application
- CNS
- Immunology
- Oncology
- Respiratory
- Others
By End-Use
- Diagnostic Companies
- Pharmaceutical Companies
- Healthcare IT companies
- Others
By Sequencing Technology
- Sequencing by Synthesis
- Ion Semiconductor Sequencing
- Sequencing by Ligation
- Pyrosequencing
- Single Molecule Real Time Sequencing
- Chain Termination Sequencing
- Nanopore Sequencing
By Product
- Consumables
- Instruments
- Services
By Route of Administration
- Oral
- Injectable
By Drugs
- Alectinib
- Osimertinib
- Mepolizumab
- Aripiprazole Lauroxil
- Others
Table of Content:
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology (Premium Insights)
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global U.S. Precision Medicine Market, By Technology
7.1. U.S. Precision Medicine Market Revenue and Volume, by Technology, 2024-2033
7.1.1. Bioinformatics
7.1.1.1. Market Revenue and Volume Forecast (2021-2033)
7.1.2. Big Data Analytics
7.1.2.1. Market Revenue and Volume Forecast (2021-2033)
7.1.3. Drug Discovery
7.1.3.1. Market Revenue and Volume Forecast (2021-2033)
7.1.4. Gene Sequencing
7.1.4.1. Market Revenue and Volume Forecast (2021-2033)
7.1.5. Companion Diagnostics
7.1.6.1. Market Revenue and Volume Forecast (2021-2033)
7.1.6. Others
7.1.5.1. Market Revenue and Volume Forecast (2021-2033)
Chapter 8. Global U.S. Precision Medicine Market, By Application
8.1. U.S. Precision Medicine Market Revenue and Volume, by Application, 2024-2033
8.1.1. CNS
8.1.1.1. Market Revenue and Volume Forecast (2021-2033)
8.1.2. Immunology
8.1.2.1. Market Revenue and Volume Forecast (2021-2033)
8.1.3. Oncology
8.1.3.1. Market Revenue and Volume Forecast (2021-2033)
8.1.4. Respiratory
8.1.4.1. Market Revenue and Volume Forecast (2021-2033)
8.1.5. Others
8.1.5.1. Market Revenue and Volume Forecast (2021-2033)
Chapter 9. Global U.S. Precision Medicine Market, By End-Use
9.1. U.S. Precision Medicine Market Revenue and Volume, by End-Use, 2024-2033
9.1.1. Diagnostic Companies
9.1.1.1. Market Revenue and Volume Forecast (2021-2033)
9.1.2. Pharmaceutical Companies
9.1.2.1. Market Revenue and Volume Forecast (2021-2033)
9.1.3. Healthcare IT companies
9.1.3.1. Market Revenue and Volume Forecast (2021-2033)
9.1.4. Others
9.1.4.1. Market Revenue and Volume Forecast (2021-2033)
Chapter 10. Global U.S. Precision Medicine Market, By Sequencing Technology
10.1. U.S. Precision Medicine Market Revenue and Volume, by Sequencing Technology, 2024-2033
10.1.1. Sequencing by Synthesis
10.1.1.1. Market Revenue and Volume Forecast (2021-2033)
10.1.2. Ion Semiconductor Sequencing
10.1.2.1. Market Revenue and Volume Forecast (2021-2033)
10.1.3. Sequencing by Ligation
10.1.3.1. Market Revenue and Volume Forecast (2021-2033)
10.1.4. Pyrosequencing
10.1.4.1. Market Revenue and Volume Forecast (2021-2033)
10.1.5. Single Molecule Real Time Sequencing
10.1.5.1. Market Revenue and Volume Forecast (2021-2033)
10.1.6. Chain Termination Sequencing
10.1.6.1. Market Revenue and Volume Forecast (2021-2033)
10.1.7. Nanopore Sequencing
10.1.7.1. Market Revenue and Volume Forecast (2021-2033)
Chapter 11. Global U.S. Precision Medicine Market, By Product
11.1. U.S. Precision Medicine Market Revenue and Volume, by Product, 2024-2033
11.1.1. Consumables
11.1.1.1. Market Revenue and Volume Forecast (2021-2033)
11.1.2. Instruments
11.1.2.1. Market Revenue and Volume Forecast (2021-2033)
11.1.3. Services
11.1.3.1. Market Revenue and Volume Forecast (2021-2033)
Chapter 12. Global U.S. Precision Medicine Market, By Route of Administration
12.1. U.S. Precision Medicine Market Revenue and Volume, by Route of Administration, 2024-2033
12.1.1. Oral
12.1.1.1. Market Revenue and Volume Forecast (2021-2033)
12.1.2. Injectable
12.1.2.1. Market Revenue and Volume Forecast (2021-2033)
Chapter 13. Global U.S. Precision Medicine Market, By Drugs
13.1. U.S. Precision Medicine Market Revenue and Volume, by Drugs, 2024-2033
13.1.1. Alectinib
13.1.1.1. Market Revenue and Volume Forecast (2021-2033)
13.1.2. Osimertinib
13.1.2.1. Market Revenue and Volume Forecast (2021-2033)
13.1.3. Mepolizumab
13.1.3.1. Market Revenue and Volume Forecast (2021-2033)
13.1.4. Aripiprazole Lauroxil
13.1.4.1. Market Revenue and Volume Forecast (2021-2033)
13.1.5. Others
13.1.5.1. Market Revenue and Volume Forecast (2021-2033)
Chapter 14. Global U.S. Precision Medicine Market, Regional Estimates and Trend Forecast
14.1. U.S.
14.1.1. Market Revenue and Volume Forecast, by Technology (2021-2033)
14.1.2. Market Revenue and Volume Forecast, by Application (2021-2033)
14.1.3. Market Revenue and Volume Forecast, by End-Use (2021-2033)
14.1.4. Market Revenue and Volume Forecast, by Sequencing Technology (2021-2033)
14.1.5. Market Revenue and Volume Forecast, by Product (2021-2033)
14.1.6. Market Revenue and Volume Forecast, by Drugs (2021-2033)
14.1.7. Market Revenue and Volume Forecast, by Route of Administration (2021-2033)
Chapter 15. Company Profiles
15.1. Biocrates Life Sciences
15.1.1. Company Overview
15.1.2. Product Offerings
15.1.3. Financial Performance
15.1.4. Recent Initiatives
15.2. Quest Diagnostics
15.2.1. Company Overview
15.2.2. Product Offerings
15.2.3. Financial Performance
15.2.4. Recent Initiatives
15.3. NanoString Technologies
15.3.1. Company Overview
15.3.2. Product Offerings
15.3.3. Financial Performance
15.3.4. Recent Initiatives
15.4. Pfizer
15.4.1. Company Overview
15.4.2. Product Offerings
15.4.3. Financial Performance
15.4.4. Recent Initiatives
15.5. AbbVie Inc.
15.5.1. Company Overview
15.5.2. Product Offerings
15.5.3. Financial Performance
15.5.4. Recent Initiatives
15.6. AstraZeneca
15.6.1. Company Overview
15.6.2. Product Offerings
15.6.3. Financial Performance
15.6.4. Recent Initiatives
15.7. Johnson & Johnson Services, Inc
15.7.1. Company Overview
15.7.2. Product Offerings
15.7.3. Financial Performance
15.7.4. Recent Initiatives
15.8. Thermo Fisher Scientific, Inc.
15.8.1. Company Overview
15.8.2. Product Offerings
15.8.3. Financial Performance
15.8.4. Recent Initiatives
15.9. Illumina, Inc.
15.9.1. Company Overview
15.9.2. Product Offerings
15.9.3. Financial Performance
15.9.4. Recent Initiatives
15.10. ARIEL Precision Medicine, Inc.
15.10.1. Company Overview
15.10.2. Product Offerings
15.10.3. Financial Performance
15.10.4. Recent Initiatives
Chapter 16. Research Methodology
16.1. Primary Research
16.2. Secondary Research
16.3. Assumptions
Chapter 17. Appendix
17.1. About Us
17.2. Glossary of Terms
Why should you invest in this report?
This report presents a compelling investment opportunity for those interested in the global U.S. precision medicine market. It serves as an extensive and informative guide, offering clear insights into this niche market. By delving into the report, you will gain a comprehensive understanding of the various major application areas for U.S. precision medicine. Furthermore, it provides crucial information about the key regions worldwide that are expected to experience substantial growth within the forecast period of 2023-2030. Armed with this knowledge, you can strategically plan your market entry approaches.
Moreover, this report offers a deep analysis of the competitive landscape, equipping you with valuable insights into the level of competition prevalent in this highly competitive market. If you are already an established player, it will enable you to assess the strategies employed by your competitors, allowing you to stay ahead as market leaders. For newcomers entering this market, the extensive data provided in this report is invaluable, providing a solid foundation for informed decision-making.
Some of the key questions answered in this report:
- What is the size of the overall U.S. precision medicine market and its segments?
- What are the key segments and sub-segments in the market?
- What are the key drivers, restraints, opportunities and challenges of the U.S. precision medicine market and how they are expected to impact the market?
- What are the attractive investment opportunities within the U.S. precision medicine market?
- What is the U.S. precision medicine market size at the regional and country-level?
- Who are the key market players and their key competitors?
- What are the strategies for growth adopted by the key players in U.S. precision medicine market?
- What are the recent trends in U.S. precision medicine market? (M&A, partnerships, new product developments, expansions)?
- What are the challenges to the U.S. precision medicine market growth?
- What are the key market trends impacting the growth of U.S. precision medicine market?
Contact Us:
Mr. Alex
Sales Manager
Call: +1 9197 992 333
Email: sales@precedenceresearch.com
Web: https://www.precedenceresearch.com
Blog: https://www.pharma-geek.com
